<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: RE: Performance enhancement with selegiline</title>
<meta name="Author" content="Rafal Smigrodzki (rafal@smigrodzki.org)">
<meta name="Subject" content="RE: Performance enhancement with selegiline">
<meta name="Date" content="2003-02-19">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>RE: Performance enhancement with selegiline</h1>
<!-- received="Wed Feb 19 10:24:15 2003" -->
<!-- isoreceived="20030219172415" -->
<!-- sent="Wed, 19 Feb 2003 12:32:18 -0500" -->
<!-- isosent="20030219173218" -->
<!-- name="Rafal Smigrodzki" -->
<!-- email="rafal@smigrodzki.org" -->
<!-- subject="RE: Performance enhancement with selegiline" -->
<!-- id="BMEDJIBJGLNDOOANGIDLMECJCKAA.rafal@smigrodzki.org" -->
<!-- charset="US-ASCII" -->
<!-- inreplyto="000001c2d6cd$71d09510$7f4a87d8@MyPC" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Rafal Smigrodzki (<a href="mailto:rafal@smigrodzki.org?Subject=RE:%20Performance%20enhancement%20with%20selegiline"><em>rafal@smigrodzki.org</em></a>)<br>
<strong>Date:</strong> Wed Feb 19 2003 - 10:32:18 MST
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3096.html">Ramez Naam: "RE: spreading democracy (was: Bush budget has 0 dollars for Afghanistan)"</a>
<ul>
<li><strong>Previous message:</strong> <a href="3094.html">Rafal Smigrodzki: "RE: Bush budget has 0 dollars for Afghanistan"</a>
<li><strong>In reply to:</strong> <a href="2898.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3085.html">Rafal Smigrodzki: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3095">[ date ]</a>
<a href="index.html#3095">[ thread ]</a>
<a href="subject.html#3095">[ subject ]</a>
<a href="author.html#3095">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
gts wrote:
<br>
<em>&gt; Gary Miller asks:
</em><br>
<em>&gt;
</em><br>
<em>&gt;&gt; Any suggestions as to how to obtain?
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;&gt; Best Source?
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;&gt; And what the estimated monthly cost of supplementation would be?
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;&gt; Did I read earlier it had to be injected?
</em><br>
<em>&gt;
</em><br>
<em>&gt; Normally selegiline (deprenyl) is not injected. It is taken orally, by
</em><br>
<em>&gt; tablet or solution.
</em><br>
<em>&gt;
</em><br>
<em>&gt; One reliable source of selegiline (deprenyl) is an overseas company
</em><br>
<em>&gt; called International Antiaging Systems (IAS). You can order online
</em><br>
<em>&gt; from IAS at www.antiaging-systems.com. I can vouch for this firm's
</em><br>
<em>&gt; integrity; I and my friends (&quot;customers&quot;)  have been doing business
</em><br>
<em>&gt; with IAS for many years.
</em><br>
<em>&gt;
</em><br>
<em>&gt; Selegiline (deprenyl) can be purchased at IAS in liquid or tablet
</em><br>
<em>&gt; form. There are some theoretical reasons to believe the liquid form is
</em><br>
<em>&gt; superior to the tablet form, but personally I take it in tablet form
</em><br>
<em>&gt; (mainly because I have a huge personal inventory of 5mg tablets).
</em><br>
<em>&gt;
</em><br>
<em>&gt; Here is pricing information about the two deprenyl products offered by
</em><br>
<em>&gt; IAS:
</em><br>
<em>&gt;
</em><br>
<em>&gt; Deprenyl Liquid (SeleprylR) 12ml 300mg bottle.
</em><br>
<em>&gt; Price:  $69.95
</em><br>
<em>&gt; This is selegiline in a citrate base. 1 drop equals 1mg. There are
</em><br>
<em>&gt; 300mg in one bottle.
</em><br>
<em>&gt;
</em><br>
<em>&gt; Deprenyl Tablets (JumexR) 50 x 5mg tablets
</em><br>
<em>&gt; Price: (3 or fewer items) $39.95
</em><br>
<em>&gt; Price: (4 or more items) $37.50
</em><br>
<em>&gt;
</em><br>
<em>&gt; The proper dosage for healthy people is probably a function of age.
</em><br>
<em>&gt; Younger people should take lower doses. A friend of mine (Dr. Ward
</em><br>
<em>&gt; Dean, M.D.) has worked out a suggested dosage schedule by age group.
</em><br>
<em>&gt; I will post it later if anyone is interested. In the meantime I
</em><br>
<em>&gt; suggest that healthy middle-aged people start with just 1 mg per day.
</em><br>
<em>&gt; This is a very small dose: it is only about 1/10 to 1/30 the dose
</em><br>
<em>&gt; used typically for purposes of treating neurodegenerative diseases
</em><br>
<em>&gt; like Parkinson's and Alzheimer's.
</em><br>
<em>&gt;
</em><br>
### It behooves you to mention that these dosages are not proven to produce
<br>
any life-prolonging or significant symptomatic relief, although on the other
<br>
hand, there is no risk of adverse effects and only minimal losses.
<br>
<p>Rafal
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3096.html">Ramez Naam: "RE: spreading democracy (was: Bush budget has 0 dollars for Afghanistan)"</a>
<li><strong>Previous message:</strong> <a href="3094.html">Rafal Smigrodzki: "RE: Bush budget has 0 dollars for Afghanistan"</a>
<li><strong>In reply to:</strong> <a href="2898.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3085.html">Rafal Smigrodzki: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3095">[ date ]</a>
<a href="index.html#3095">[ thread ]</a>
<a href="subject.html#3095">[ subject ]</a>
<a href="author.html#3095">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Wed Feb 19 2003 - 10:26:42 MST
</em></small></p>
</body>
</html>
